Clinical Oncology
Volume 22, Issue 2 , Pages 136-139, March 2010

Should We Routinely Offer a Second Admission for Radioiodine to Patients with High-risk Differentiated Thyroid Cancer?

  • G.E. Gerrard

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: G.E. Gerrard, St James Institute of Oncology, St James's Hospital, Becket Street, Leeds LS9 7TF, UK. Tel: +44-113-2068336; Fax: +44-113-2067534.
    • ,
  • L. O'Toole
    • ,
  • F. Roberts

St James Institute of Oncology, St James's Hospital, Becket Street, Leeds LS9 7TF, UK

Received 1 October 2009; received in revised form 14 December 2009; accepted 21 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(10)00005-1

doi:10.1016/j.clon.2010.01.002

Clinical Oncology
Volume 22, Issue 2 , Pages 136-139, March 2010

Article Tools